MaxCyte, Inc. (MXCT) Tops Q3 EPS by 1c
Tweet
Share
E-mail
Get Alerts MXCT Hot Sheet
Join SI Premium – FREE
MaxCyte, Inc. (NASDAQ: MXCT) reported Q3 EPS of ($0.11), $0.01 better than the analyst estimate of ($0.12). Revenue for the quarter came in at $8.2 million versus the consensus estimate of $7.46 million.
For earnings history and earnings-related data on MaxCyte, Inc. (MXCT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Oman Warned European Allies Ship Fees Likely Needed For Hormuz - Bloomberg
- Increasing unusual option volume: WEN DOMO EQPT OPTU TSLT CAPR ASND SGOL
- Cumberland Pharmaceuticals shares updated DMD cardiac trial data
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
